Stay updated on EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page
- Check5 days agoChange DetectedThe page footer revision changes from v3.5.4 to v3.5.5, signaling a new site version or template update. There are no reported changes to the study data or content; it's a maintenance update.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedNo textual changes are present in the provided data; the page content appears unchanged based on the given input.SummaryDifference0.1%

- Check26 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page metadata.SummaryDifference0.1%

- Check48 days agoChange DetectedThe study details page now shows a newer software/document revision identifier (updating the version from v3.5.2 to v3.5.3). This indicates a technical page update rather than a change to the study information itself.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check69 days agoChange DetectedRHYNS syndrome was added as a related term in the study record. This improves indexing and discoverability without changing the study procedures.SummaryDifference0.1%

Stay in the know with updates to EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.